FDA Import Alerts: How to Avoid Costs and Delays and Get Your Goods Removed
Webinar: 1 CCS Credit
The Food and Drug Administration issues import alerts to indicate that a company, product, or country will have goods detained without physical examination until they are shown to be compliant by independent testing. Placement on an import alert can cause immense disruption, including added test costs, product delays, unhappy customers, and dents in a company’s profits. This webinar will examine how to avoid getting, or increase your chances for getting off, an import alert.
- overview of import alerts: what they mean and how companies are placed
- who is obligated to learn of a company’s placement on an import alert
- contractual agreements
- seeking removal from an import alert
- FSMA implications
- compliance strategies
Shelly Garg leads Sandler, Travis & Rosenberg’s FDA Practice Group and represents clients across a broad range of FDA-regulated product categories, including foods, beverages, dietary supplements, over-the-counter drugs, medical devices, and cosmetics. She advises in strategic business planning, product development, testing and approval, labeling, advertisement and promotion, liability risk, inspections, responding to regulatory enforcement matters, and related issues.